Procept Biorobotics Corp
NASDAQ:PRCT
Cash Flow Statement
Cash Flow Statement
Procept Biorobotics Corp
| Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||||||
| Net Income |
(55)
|
(57)
|
(60)
|
(77)
|
(69)
|
(77)
|
(87)
|
(98)
|
(105)
|
(107)
|
(106)
|
(103)
|
(104)
|
(100)
|
(91)
|
(90)
|
(84)
|
(85)
|
|
| Depreciation & Amortization |
3
|
3
|
3
|
4
|
3
|
3
|
3
|
3
|
3
|
3
|
4
|
4
|
5
|
5
|
5
|
6
|
6
|
6
|
|
| Stock-Based Compensation |
4
|
4
|
4
|
5
|
7
|
9
|
10
|
13
|
15
|
17
|
19
|
22
|
25
|
28
|
32
|
36
|
40
|
46
|
|
| Other Non-Cash Items |
3
|
4
|
4
|
5
|
6
|
10
|
15
|
18
|
21
|
22
|
20
|
22
|
26
|
29
|
34
|
39
|
42
|
48
|
|
| Cash Interest Paid |
5
|
5
|
5
|
6
|
5
|
5
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
|
| Change in Working Capital |
(4)
|
(4)
|
(5)
|
(8)
|
(5)
|
(7)
|
(11)
|
(21)
|
(28)
|
(27)
|
(26)
|
(27)
|
(19)
|
(26)
|
(47)
|
(38)
|
(47)
|
(41)
|
|
| Cash from Operating Activities |
(53)
N/A
|
(54)
-3%
|
(57)
-6%
|
(76)
-32%
|
(65)
+15%
|
(72)
-11%
|
(80)
-12%
|
(98)
-22%
|
(109)
-11%
|
(108)
+1%
|
(108)
+0%
|
(104)
+3%
|
(92)
+12%
|
(92)
+0%
|
(99)
-8%
|
(84)
+15%
|
(83)
+1%
|
(71)
+15%
|
|
| Investing Cash Flow | |||||||||||||||||||
| Capital Expenditures |
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(2)
|
(3)
|
(8)
|
(13)
|
(17)
|
(25)
|
(22)
|
(17)
|
(12)
|
(4)
|
(4)
|
(6)
|
(9)
|
|
| Other Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Investing Activities |
(0)
N/A
|
(0)
-50%
|
(1)
-119%
|
(1)
-10%
|
(1)
-9%
|
(2)
-199%
|
(3)
-25%
|
(8)
-199%
|
(13)
-65%
|
(17)
-33%
|
(25)
-45%
|
(22)
+13%
|
(17)
+20%
|
(12)
+32%
|
(4)
+63%
|
(4)
+2%
|
(6)
-41%
|
(9)
-43%
|
|
| Financing Cash Flow | |||||||||||||||||||
| Net Issuance of Common Stock |
167
|
262
|
262
|
263
|
179
|
6
|
6
|
6
|
5
|
166
|
168
|
170
|
173
|
12
|
180
|
179
|
178
|
177
|
|
| Net Issuance of Debt |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other |
0
|
0
|
0
|
0
|
0
|
0
|
(4)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Financing Activities |
167
N/A
|
262
+57%
|
262
+0%
|
263
+0%
|
179
-32%
|
6
-97%
|
4
-35%
|
3
-25%
|
2
-16%
|
164
+7 107%
|
168
+3%
|
170
+1%
|
173
+2%
|
12
-93%
|
180
+1 345%
|
179
-1%
|
178
-1%
|
177
0%
|
|
| Change in Cash | |||||||||||||||||||
| Effect of Foreign Exchange Rates |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
|
| Net Change in Cash |
114
N/A
|
207
+81%
|
204
-1%
|
187
-8%
|
114
-39%
|
(68)
N/A
|
(79)
-16%
|
(103)
-30%
|
(120)
-16%
|
38
N/A
|
35
-9%
|
44
+27%
|
64
+45%
|
(91)
N/A
|
77
N/A
|
91
+18%
|
89
-2%
|
98
+10%
|
|
| Free Cash Flow | |||||||||||||||||||
| Free Cash Flow |
(53)
N/A
|
(55)
-4%
|
(58)
-6%
|
(76)
-32%
|
(65)
+14%
|
(74)
-13%
|
(83)
-13%
|
(106)
-28%
|
(122)
-15%
|
(126)
-3%
|
(133)
-6%
|
(126)
+5%
|
(109)
+13%
|
(104)
+5%
|
(104)
0%
|
(88)
+15%
|
(89)
-1%
|
(80)
+11%
|
|